Serum free light chains in clinical laboratory diagnostics (original) (raw)
Comparison of the free and total light chain assays in serum and urine samples with immunofixation electrophoresis for detecting monoclonal proteins in patients with monoclonal gammopathy
Marta Morawska
Current Issues in Pharmacy and Medical Sciences, 2014
View PDFchevron_right
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders
M. Boccadoro, Giampaolo Merlini
Leukemia, 2009
View PDFchevron_right
Quantitation of Serum Free Light Chains in Combination with Protein Electrophoresis and Clinical Information for Diagnosing Multiple Myeloma in a General Hospital Population
Nina Gulbrandsen
Clinical Chemistry, 2008
View PDFchevron_right
Diagnostic Performance of Quantitative and Free Light Chain Assays in Clinical Practice
Angela Dispenzieri
Clinical Chemistry, 2005
View PDFchevron_right
Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure
Tim Plant
BMC Nephrology, 2008
View PDFchevron_right
Serum free light chains should be the target of response evaluation in light chain multiple myeloma rather than urines
Aurore Perrot
Blood, 2016
View PDFchevron_right
The Value of Serum Immunoglobulin Free Light Chain Assessment in Patients with Monoclonal Gammopathies and Acute Renal Failure
Mustafa Cirit
Turkish Journal of Hematology, 2012
View PDFchevron_right
Understanding the Constraints and Optimization of Serum Immunofixation Electrophoresis and Serum Free Light Chains for Detecting Monoclonal Proteins: A Single-Center Experience
Malvika Shastri
Journal of Laboratory Physicians
View PDFchevron_right
Free immunoglobulin light-chain serum levels in the follow-up of patients with monoclonal gammopathies: Correlation with 24-hr urinary light-chain excretion
Pierre Aucouturier
American Journal of Hematology, 2004
View PDFchevron_right
Serum free light chain measurements to reduce 24-h urine monitoring in patients with multiple myeloma with measurable urine monoclonal protein
David Dingli
American journal of hematology, 2018
View PDFchevron_right
Serum free light chains, not urine specimens, should be used to evaluate response in light-chain multiple myeloma
Aurore Perrot
Blood, 2016
View PDFchevron_right
Defining the impact of individual sample variability on routine immunoassay of serum free light chains (sFLC) in multiple myeloma
S. Murng
Clinical & Experimental Immunology, 2013
View PDFchevron_right
Multiple myeloma can be accurately diagnosed in acute kidney injury patients using a rapid serum free light chain test
Jennifer Pinney
BMC nephrology, 2017
View PDFchevron_right
A new free light chain immunoassay shows advantages in the classification and in the follow-up of patients with paraproteinemia compared to a nephelometric assay
OSMAN EVLİYAOĞLU
Hematology and Medical Oncology, 2019
View PDFchevron_right
Abnormal serum free light chain ratio does not always indicate monoclonal gammopathy
Bogdan Ochrem
Polskie Archiwum Medycyny Wewnętrznej, 2015
View PDFchevron_right
The Current Role of the Heavy/Light Chain Assay in the Diagnosis, Prognosis and Monitoring of Multiple Myeloma: An Evidence-Based Approach
Alberto Leivas
Diagnostics
View PDFchevron_right
IMMUNOGLOBULINS DETECTION AS BIOLOGICAL MARKERS OF MULTIPLE MYELOMA
Anil Batta
View PDFchevron_right
Serum Free Light Chain Ratio, Total / Ratio, and Immunofixation Results Are Not Prognostic Factors after Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma
Luisa Giaccone
Clinical Chemistry, 2009
View PDFchevron_right
Diagnosis and monitoring for light chain only and oligosecretory myeloma using serum free light chain tests
James Child
British journal of haematology, 2017
View PDFchevron_right
Serum free light chain levels and renal function at diagnosis in patients with multiple myeloma
Jennifer Pinney
BMC nephrology, 2018
View PDFchevron_right
Diagnostic sensitivity of a panel of tests to detect monoclonal protein in Korean multiple myeloma patients
Woochang Lee
Clinical Chemistry and Laboratory Medicine, 2013
View PDFchevron_right
Role of Serum Free Light Chain Assay in Relapsed/Refractory Multiple Myeloma. A Real-Life Unicentric Retrospective Study
uros markovic
Cancers, 2021
View PDFchevron_right
Immunoglobulin heavy/light chain analysis enhances the detection of residual disease and monitoring of multiple myeloma patients
I. Radman, Klara Dubravcic
Croatian medical journal, 2015
View PDFchevron_right
Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma
Tatiana Tzenou
British Journal of Haematology, 2007
View PDFchevron_right
Development of a rapid and quantitative lateral flow assay for the simultaneous measurement of serum κ and λ immunoglobulin free light chains (FLC): inception of a new near-patient FLC screening tool
Tim Plant
Clinical chemistry and laboratory medicine, 2016
View PDFchevron_right
The correlation of serum immunoglobulin free light chain levels and selected biological markers in multiple myeloma
Katerina Langova
Biomedical Papers, 2008
View PDFchevron_right
Prediction of response and progression in multiple myeloma with serum free light chains assay: corroboration of the serum free light chain response definitions
Mohamad Hussein
Clinical lymphoma, myeloma & leukemia, 2010
View PDFchevron_right